Annual accounts receivable:
$40.41M+$1.22M(+3.11%)Summary
- As of today (September 16, 2025), XERS annual accounts receivable is $40.41 million, with the most recent change of +$1.22 million (+3.11%) on December 31, 2024.
- During the last 3 years, XERS annual accounts receivable has risen by +$22.96 million (+131.52%).
- XERS annual accounts receivable is now at all-time high.
Performance
XERS Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$53.05M+$6.72M(+14.50%)Summary
- As of today (September 16, 2025), XERS quarterly accounts receivable is $53.05 million, with the most recent change of +$6.72 million (+14.50%) on June 30, 2025.
- Over the past year, XERS quarterly accounts receivable has increased by +$10.61 million (+25.00%).
- XERS quarterly accounts receivable is now at all-time high.
Performance
XERS Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XERS Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | +25.0% |
| 3 y3 years | +131.5% | +106.0% |
| 5 y5 years | +761.2% | +1572.9% |
XERS Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +131.5% | at high | +106.0% |
| 5 y | 5-year | at high | +761.2% | at high | +1572.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
XERS Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $53.05M(+14.5%) |
| Mar 2025 | - | $46.33M(+14.6%) |
| Dec 2024 | $40.41M(+3.1%) | $40.41M(-1.8%) |
| Sep 2024 | - | $41.14M(-3.1%) |
| Jun 2024 | - | $42.44M(+13.4%) |
| Mar 2024 | - | $37.41M(-4.5%) |
| Dec 2023 | $39.20M(+27.1%) | $39.20M(-14.7%) |
| Sep 2023 | - | $45.97M(+52.1%) |
| Jun 2023 | - | $30.23M(-2.1%) |
| Mar 2023 | - | $30.86M(+0.1%) |
| Dec 2022 | $30.83M(+76.6%) | $30.83M(+12.0%) |
| Sep 2022 | - | $27.52M(+6.8%) |
| Jun 2022 | - | $25.76M(+10.1%) |
| Mar 2022 | - | $23.38M(+34.0%) |
| Dec 2021 | $17.46M | $17.46M(+28.7%) |
| Sep 2021 | - | $13.56M(+10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $12.29M(+37.6%) |
| Mar 2021 | - | $8.94M(+30.0%) |
| Dec 2020 | $6.88M(+46.5%) | $6.88M(-42.4%) |
| Sep 2020 | - | $11.93M(+276.2%) |
| Jun 2020 | - | $3.17M(+25.3%) |
| Mar 2020 | - | $2.53M(-55.1%) |
| Dec 2019 | $4.69M(>+9900.0%) | $5.64M(+545.2%) |
| Sep 2019 | - | $874.00K(+5.8%) |
| Jun 2019 | - | $826.00K(-77.2%) |
| Mar 2019 | - | $3.63M(+26.5%) |
| Dec 2018 | $0.00(-100.0%) | $2.87M(+65.7%) |
| Sep 2018 | - | $1.73M(+62.5%) |
| Jun 2018 | - | $1.06M(+271.1%) |
| Mar 2018 | - | $287.00K(-76.1%) |
| Dec 2017 | $1.20M(+1087.1%) | $1.20M |
| Dec 2016 | $101.00K | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual accounts receivable year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly accounts receivable year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual accounts receivable?
The current annual accounts receivable of XERS is $40.41M
What is the all time high annual accounts receivable for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual accounts receivable is $40.41M
What is Xeris Biopharma Holdings, Inc. annual accounts receivable year-on-year change?
Over the past year, XERS annual accounts receivable has changed by +$1.22M (+3.11%)
What is Xeris Biopharma Holdings, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of XERS is $53.05M
What is the all time high quarterly accounts receivable for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly accounts receivable is $53.05M
What is Xeris Biopharma Holdings, Inc. quarterly accounts receivable year-on-year change?
Over the past year, XERS quarterly accounts receivable has changed by +$10.61M (+25.00%)